Close Menu

NEW YORK – Euroimmun said on Thursday it has received the CE mark for its SARS-CoV-2 Neutralisa assay.

The surrogate neutralization test is for detecting neutralizing antibodies against SARS-CoV-2. Euroimmun, a PerkinElmer subsidiary, said that antibodies that target the viral receptor binding domain (RBD) in the S1 domain of SARS-CoV-2 have been shown to have a virus-neutralizing ability, predominantly in the form of IgG antibodies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.